Cvent Unveils 2018 List of Top 50 Meeting Hotels in Europe
Cvent, Inc., a market leader in meetings, events, and hospitality technology, today announced the results of its Top 50 Meeting Hotels in Europe . Due to increased group business demand, venues in Europe are ranked in a standalone list this year after previously being included in the Europe, Middle East, and Africa category. The list was compiled by analysing group booking activity through its Cvent Supplier Network, which sourced more than $14.7 billion and more than 40 million room nights in 2017, helping to support more than 715,000 events worldwide.
“With industry research showing the current global value of the MICE industry at $750+ billion and growing substantially, and Europe dominating with a market share of 42%*, there is huge potential for hotels across the region to capitalise on group business opportunities,” said Bharet Malhotra, Senior Vice President of Sales for Cvent’s Hospitality Cloud. “Based on these market trends, it made sense for us to provide a European-only list that would offer the industry what they are looking for: top European venues for their meetings and events.”
Europe List Highlights:
- Hilton took the top three spots for generating the most MICE business in Europe: Hilton Prague, Hilton London Metropole, The Double Tree by Hilton, Amsterdam Centraal Station in that order.
- Marriott, Hilton, and IHG (in that order) are the top three hotel chains represented on the Top 50 list.
Germany and Spain represent the largest selection of hotels on the
list with 12 and 10 in the Top 50 respectively including the following
chains and brands:
- Radisson Blu, Sheraton, NH Hotel Group, Renaissance, W Hotels, Melia, and AccorHotels
“I am truly proud to see Hilton Prague being recognized,” said Hilton Prague General Manager Michael Specking. “Hilton Prague is a fantastic contemporary venue of 800 bedrooms and 5,000 sq. meters of convention space in a fabulous downtown location, and it’s the team’s focus to consistently deliver high level of services to make our promise happen: ‘Your vision, our passion.’”
“We saw many large-scale renovations in the European market this year as venues vie for group business and look to attract the large number of international conferences hosted in the region,” said Chris McAndrews, Vice President of Marketing for Cvent’s Hospitality Cloud. “With such big changes and new entries making it into the Top 50 list this year, and an increasing number of hotels keen to invest to meet the requirements of the 21st century business traveller, it will be interesting to see this time next year who will take the top spots.”
Due to increased demand and buyer preferences, Cvent also announced it has expanded its list categories to include sub-lists which segment venues further based on commonly searched attributes including property type, conference space size, and region-specific locales. These lists will be announced over the coming weeks.
Top 10 Hotel Properties in Europe:
For the complete Top 50 table please see HERE
|2018 Rank||Hotel Name|
|2||Hilton London Metropole|
|3||DoubleTree by Hilton, Amsterdam Centraal Station|
|4||Hotel Arts Barcelona|
|5||Sheraton Frankfurt Airport Hotel & Conference Centre|
|6||Hilton Munich Park|
|7||Hilton Diagonal Mar Barcelona|
|8||Rome Marriott Park Hotel|
|9||Hilton London Paddington|
Cvent evaluated hotel properties that generated business through the Cvent Supplier Network from January 2017 through December 2017. The properties were ranked according to various criteria, including total requests for proposals (RFPs), awarded RFPs, total room nights, awarded room nights, major metropolitan area (MMA) market share, conversion rate, and the hotel's unique profile visits in the Cvent Supplier Network. The criteria are designed to provide the most accurate reflection of the top meeting hotels in the U.S., Europe, Middle East and Africa, and Asia Pacific regions.
*Allied Market Research, Jan 2018
About the Cvent Supplier Network
Featuring more than 255,000 hotels, resorts and special event venues, the Cvent Supplier Network is one of the world's largest and most accurate databases of detailed venue information. Cvent sourced more than $14.7 billion in meetings and events through its marketplace and more than 40 Million room nights in 2017. The CSN contains listings of hotels and other venues in more than 175 countries that can be searched and filtered based on approximately 200 meetings and events attributes. The Network is part of the Cvent Hospitality Cloud, which provides hotels, CVBs and other event venue owners, solutions to effectively generate qualified demand for meetings and events, manage that demand more efficiently, and measure group business performance.
For more information regarding the Cvent Supplier Network, visit www.cvent.com/venues.
Cvent, Inc. is a leading cloud-based enterprise event management company with more than 25,000 customers, 300,000 users, and 3,000 employees worldwide. Cvent offers software solutions to event planners for online event registration, venue selection, event management, mobile apps for events, email marketing, and web surveys. Cvent provides hoteliers with an integrated platform, enabling properties to increase group business demand through targeted advertising and improve conversion through proprietary demand management and business intelligence solutions. Cvent solutions optimize the entire event management value chain and have enabled clients around the world to manage hundreds of thousands of meetings and events. For more information, please visit Cvent.com/UK or connect with us on Facebook, Twitter or LinkedIn.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 12:00 | Pressemelding
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 12:00 | Pressemelding
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 11:27 | Pressemelding
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00 | Pressemelding
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11 | Pressemelding
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo